Regentis Biomaterials
-
Biologics
TRIA Orthopedics First in Minnesota to Test Breakthrough GelrinC™ Implant to Regenerate Knee Cartilage
November 27, 2018 MINNEAPOLIS–(BUSINESS WIRE)–Regentis Biomaterials today announced that Twin Cities-based TRIA Orthopedics is the first in Minnesota to perform…
Read More » -
Biologics
Regentis Biomaterials Expands SAGE Clinical Trial of GelrinC™ for Knee Pain
October 23, 2018 PRINCETON, N.J. & OR AKIVA, Israel–(BUSINESS WIRE)–Regentis Biomaterials today announced it has expanded the SAGE clinical trial of GelrinC™…
Read More » -
Biologics
Regentis Biomaterials Performs the First Cases in GelrinC Pivotal Study
PRINCETON, New Jersey and OR AKIVA, Israel, November 28, 2017 /PRNewswire/ — Regentis Biomaterials announced today the start of its Phase III pivotal clinical trial…
Read More » -
Biologics
Regentis Biomaterials Receives European CE Mark Approval for GelrinC
OR AKIVA, Israel and PRINCETON, New Jersey, August 28, 2017 /PRNewswire/ — Regentis Biomaterials Ltd., a privately held company developing proprietary hydrogels for tissue regeneration,…
Read More »